[go: up one dir, main page]

EA200300450A1 - Фармацевтические растворы соединений модафинила - Google Patents

Фармацевтические растворы соединений модафинила

Info

Publication number
EA200300450A1
EA200300450A1 EA200300450A EA200300450A EA200300450A1 EA 200300450 A1 EA200300450 A1 EA 200300450A1 EA 200300450 A EA200300450 A EA 200300450A EA 200300450 A EA200300450 A EA 200300450A EA 200300450 A1 EA200300450 A1 EA 200300450A1
Authority
EA
Eurasian Patent Office
Prior art keywords
modafinil
compounds
pharmaceutical solutions
modafinil compounds
pharmaceutical
Prior art date
Application number
EA200300450A
Other languages
English (en)
Other versions
EA005572B1 (ru
Inventor
Мартин Дж. Джейкобз
Брэдли Т. Макинтайр
Пиюш Р. Пейтел
Original Assignee
Сефалон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сефалон, Инк. filed Critical Сефалон, Инк.
Publication of EA200300450A1 publication Critical patent/EA200300450A1/ru
Publication of EA005572B1 publication Critical patent/EA005572B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описаны фармацевтические композиции соединений модафинила, а также фармацевтические неводные композиции соединений модафинила в органических растворителях, наряду с их применением для лечения заболеваний.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300450A 2000-10-11 2001-10-11 Фармацевтические растворы соединений модафинила EA005572B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23948800P 2000-10-11 2000-10-11
US09/974,473 US6489363B2 (en) 2000-10-11 2001-10-10 Pharmaceutical solutions of modafinil compounds
PCT/US2001/031685 WO2002030413A1 (en) 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds

Publications (2)

Publication Number Publication Date
EA200300450A1 true EA200300450A1 (ru) 2003-08-28
EA005572B1 EA005572B1 (ru) 2005-04-28

Family

ID=26932612

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300450A EA005572B1 (ru) 2000-10-11 2001-10-11 Фармацевтические растворы соединений модафинила

Country Status (21)

Country Link
US (1) US6489363B2 (ru)
EP (1) EP1324755B1 (ru)
JP (1) JP2004510816A (ru)
KR (1) KR100846914B1 (ru)
CN (1) CN100518726C (ru)
AT (1) ATE478662T1 (ru)
AU (2) AU9678501A (ru)
BG (1) BG66221B1 (ru)
BR (1) BR0114813A (ru)
CA (1) CA2425218C (ru)
CZ (1) CZ2003966A3 (ru)
DE (1) DE60142913D1 (ru)
EA (1) EA005572B1 (ru)
HU (1) HU229424B1 (ru)
IL (2) IL155263A0 (ru)
MX (1) MXPA03003150A (ru)
NO (1) NO333096B1 (ru)
NZ (1) NZ525166A (ru)
PL (1) PL214879B1 (ru)
SK (1) SK287436B6 (ru)
WO (1) WO2002030413A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA032913B1 (ru) * 2012-10-18 2019-08-30 Эббви Инк. Препараты производных пиримидиндиона

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CN100584322C (zh) * 2000-10-11 2010-01-27 赛福伦公司 包含莫达非尼化合物的组合物
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
AU2004222307B2 (en) * 2003-03-17 2008-04-17 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US8153159B2 (en) * 2003-09-18 2012-04-10 Cephalon, Inc. Modafinil modified release pharmaceutical compositions
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
US7884135B2 (en) * 2006-08-14 2011-02-08 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
CA2629979A1 (en) * 2008-04-25 2009-10-25 Pharmascience Inc. Novel resveratrol compositions
FR2987266B1 (fr) 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
FR2987265B1 (fr) 2012-02-28 2014-02-28 Debregeas Et Associes Pharma Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6200968B1 (en) 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA032913B1 (ru) * 2012-10-18 2019-08-30 Эббви Инк. Препараты производных пиримидиндиона

Also Published As

Publication number Publication date
CZ2003966A3 (cs) 2003-09-17
AU9678501A (en) 2002-04-22
NO20031648D0 (no) 2003-04-10
JP2004510816A (ja) 2004-04-08
EA005572B1 (ru) 2005-04-28
MXPA03003150A (es) 2003-07-14
BG107720A (bg) 2004-01-30
NO20031648L (no) 2003-06-04
CN100518726C (zh) 2009-07-29
PL361134A1 (en) 2004-09-20
US6489363B2 (en) 2002-12-03
KR20030055279A (ko) 2003-07-02
HU229424B1 (hu) 2013-12-30
EP1324755B1 (en) 2010-08-25
PL214879B1 (pl) 2013-09-30
EP1324755A1 (en) 2003-07-09
CA2425218A1 (en) 2002-04-18
KR100846914B1 (ko) 2008-07-17
AU2001296785B2 (en) 2006-03-16
DE60142913D1 (de) 2010-10-07
BG66221B1 (bg) 2012-06-29
CA2425218C (en) 2010-10-05
WO2002030413A1 (en) 2002-04-18
HUP0302478A3 (en) 2005-05-30
IL155263A0 (en) 2003-11-23
SK4402003A3 (en) 2003-09-11
ATE478662T1 (de) 2010-09-15
BR0114813A (pt) 2005-01-25
SK287436B6 (sk) 2010-09-07
NO333096B1 (no) 2013-03-04
HUP0302478A2 (hu) 2003-11-28
US20020099097A1 (en) 2002-07-25
NZ525166A (en) 2006-10-27
CN1468096A (zh) 2004-01-14
IL155263A (en) 2007-07-24
HK1057336A1 (en) 2004-04-02

Similar Documents

Publication Publication Date Title
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200200316A1 (ru) Соединения для лечения ишемии
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
DE60322412D1 (de) Pharmazeutische feste Dispersionen von Modafinil-Verbindungen
EA200400586A1 (ru) Замещённые тиоацетамиды
EA200501162A1 (ru) Пиразолилкарбоксанилиды для борьбы с нежелательными микроорганизмами
EA200500528A1 (ru) Пиперазинил- и диазапанилбензамиды и бензтиоамиды
EA200400086A1 (ru) Новые производные оксазолидинонов в качестве антибактериальных агентов
EA200300062A1 (ru) Производные аминоалкилбензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
EA200300597A1 (ru) Бифенилкарбоксамиды, полезные в качестве снижающих содержание липидов агентов
EA200400530A1 (ru) Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин"
EA200501341A1 (ru) Противобактериальные индолоноксазолидиноны, промежуточные соединения для их получения и содержащие их фармацевтические композиции
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU